Product NewsClinical Diagnostics
MSACL testimonial from Dr. Michael Lutz
20 Nov 2023![MSACL testimonial from Dr. Michael Lutz MSACL testimonial from Dr. Michael Lutz](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/73d54280a35db636665d83ab33646a2e3c6c9210-805x450.jpg?w=3840&q=75&fit=clip&auto=format)
In this video, Thermo Fisher Scientific presents a testimonial from Dr. Michael Lutz, senior advisor at Osteolabs, a diagnostic company specializing in clinical assays for metabolic bone disorders. Dr. Lutz discusses how the use of inductively coupled plasma mass spectrometry (ICP-MS) methods developed by Osteolabs will impact over 1 billion patients with metabolic bone diseases around the world.